1,003
Views
15
CrossRef citations to date
0
Altmetric
Clinical Research

Loperamide misuse to avoid opioid withdrawal and to achieve a euphoric effect: high doses and high risk

, , , , , , , & show all
Pages 175-180 | Received 17 May 2018, Accepted 06 Aug 2018, Published online: 26 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mohammad Algarni, Muhammad Abdul Hadi, Asma Yahyouche, Sajid Mahmood & Zahraa Jalal. (2021) A mixed-methods systematic review of the prevalence, reasons, associated harms and risk-reduction interventions of over-the-counter (OTC) medicines misuse, abuse and dependence in adults. Journal of Pharmaceutical Policy and Practice 14:1.
Read now
William Eggleston, Robert Palmer, Pierre-André Dubé, Stephen Thornton, Andrew Stolbach, Diane P Calello & Jeanna M Marraffa. (2020) Loperamide toxicity: recommendations for patient monitoring and management. Clinical Toxicology 58:5, pages 355-359.
Read now

Articles from other publishers (13)

Muna Barakat, Amal Akour, Diana Malaeb, Sarah Cherri, Wala’a Al.Safadi, Ala’a Al.Safadi & Mayyada Wazaify. (2023) Perspectives of and Experience toward the Abuse of Antidiarrheal Drug (Loperamide) among Community Pharmacists: A Cross-Sectional Study. International Journal of Environmental Research and Public Health 20:14, pages 6400.
Crossref
Bruna Cremonezi Lammoglia, Gabriela Hasselmann, Marcelo Pires-Oliveira, Lucas Antonio Duarte Nicolau, Jand Venes Rolim Medeiros, Fernando Sabia Tallo, Murched Omar Taha, Rildo Yamaguti Lima, Afonso Caricati-Neto & Francisco Sandro Menezes-Rodrigues. (2022) Risk of Cardiac Lesion with Chronic and Acute Use of Loperamide—An Integrative Review. Journal of Cardiovascular Development and Disease 9:12, pages 431.
Crossref
K Aaron Geno, Adina Badea, Kara L Lynch, Paul Jannetto, Jacqueline A Hubbard, Robert D Nerenz & Mark A Cervinski. (2022) An Opioid Hiding in Plain Sight: Loperamide-Induced False-Positive Fentanyl and Buprenorphine Immunoassay Results. The Journal of Applied Laboratory Medicine 7:6, pages 1318-1328.
Crossref
Peter E. Wu & David N. Juurlink. (2022) Loperamide Cardiac Toxicity: Pathophysiology, Presentation, and Management. Canadian Journal of Cardiology 38:9, pages 1378-1383.
Crossref
Ashley Mason, Gavin Lockard, Vance Cantrell, Snow Pinxue Li, Kirtan Patel, Sierra Klein, Andre Elder, Melissa Sur & Charles Preuss. 2022. Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology. Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology 285 301 .
Cori A. Malinky, Craig W. Lindsley & Changho Han. (2021) DARK Classics in Chemical Neuroscience: Loperamide. ACS Chemical Neuroscience 12:16, pages 2964-2973.
Crossref
David Vearrier & Oliver Grundmann. (2021) Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids. The Journal of Clinical Pharmacology 61:S2.
Crossref
Jerome De Vera, Hyungjin Ben Kim & Antoine E. Sakr. (2021) A Case Report of Loperamide-Induced Ventricular Storm. Journal of Investigative Medicine High Impact Case Reports 9, pages 232470962199076.
Crossref
F. Schifano, F. Napoletano, S. Chiappini, A. Guirguis, J. M. Corkery, S. Bonaccorso, A. Ricciardi, N. Scherbaum & A. Vento. (2019) New/emerging psychoactive substances and associated psychopathological consequences. Psychological Medicine 51:1, pages 30-42.
Crossref
Ryan Feldman & Erik Everton. (2020) National assessment of pharmacist awareness of loperamide abuse and ability to restrict sale if abuse is suspected. Journal of the American Pharmacists Association 60:6, pages 868-873.
Crossref
Feng Sheng & Michael C Milone. (2019) Commentary. Clinical Chemistry 65:11, pages 1361-1361.
Crossref
Monica R Hill, Mark R Hopkins & Claire E Knezevic. (2019) Emerging Toxidromes: A 25-Year-Old Woman with Syncope and ECG Changes. Clinical Chemistry 65:11, pages 1357-1360.
Crossref
. (2019) Loperamide. Reactions Weekly 1749:1, pages 242-242.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.